[{"address1": "1375 West Fulton Street", "address2": "Suite 1300", "city": "Chicago", "state": "IL", "zip": "60607", "country": "United States", "phone": "844 445 5704", "website": "https://www.xerispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 394, "companyOfficers": [{"maxAge": 1, "name": "Mr. John P. Shannon", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1065572, "exercisedValue": 0, "unexercisedValue": 341267}, {"maxAge": 1, "name": "Mr. Kevin  McCulloch", "age": 60, "title": "President & COO", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 777048, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven M. Pieper", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 747017, "exercisedValue": 30004, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth P. Hecht J.D.", "age": 60, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 767825, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Edick J.D.", "age": 68, "title": "Senior Advisor", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 2597639, "exercisedValue": 0, "unexercisedValue": 1357712}, {"maxAge": 1, "name": "Ms. Allison  Wey", "title": "Senior Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Conner", "title": "SVP of Quality and Chief Compliance & Risk Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kendal  Korte", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anh  Nguyen M.B.A., M.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.67, "open": 4.65, "dayLow": 4.54, "dayHigh": 4.705, "regularMarketPreviousClose": 4.67, "regularMarketOpen": 4.65, "regularMarketDayLow": 4.54, "regularMarketDayHigh": 4.705, "payoutRatio": 0.0, "beta": 0.909, "forwardPE": -21.090908, "volume": 1131075, "regularMarketVolume": 1131075, "averageVolume": 2395590, "averageVolume10days": 2314470, "averageDailyVolume10Day": 2314470, "bid": 4.6, "ask": 4.71, "bidSize": 2, "askSize": 1, "marketCap": 743119232, "fiftyTwoWeekLow": 2.03, "fiftyTwoWeekHigh": 6.07, "priceToSalesTrailing12Months": 3.3390963, "fiftyDayAverage": 4.619, "twoHundredDayAverage": 3.86115, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 958234880, "profitMargins": -0.20254, "floatShares": 152803886, "sharesOutstanding": 160155008, "sharesShort": 17940320, "sharesShortPriorMonth": 17803095, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.111999996, "heldPercentInsiders": 0.04188, "heldPercentInstitutions": 0.54497004, "shortRatio": 8.71, "shortPercentOfFloat": 0.1166, "impliedSharesOutstanding": 161518000, "bookValue": -0.225, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -45076000, "trailingEps": -0.29, "forwardEps": -0.22, "enterpriseToRevenue": 4.306, "enterpriseToEbitda": -221.148, "52WeekChange": 1.2669902, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 4.64, "targetHighPrice": 7.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.3, "targetMedianPrice": 7.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 58440000, "totalCashPerShare": 0.365, "ebitda": -4333000, "totalDebt": 268751008, "quickRatio": 1.102, "currentRatio": 1.72, "totalRevenue": 222551008, "revenuePerShare": 1.486, "returnOnAssets": -0.03142, "grossProfits": 182962000, "freeCashflow": -5904125, "operatingCashflow": -26709000, "revenueGrowth": 0.479, "grossMargins": 0.82211, "ebitdaMargins": -0.01947, "operatingMargins": -0.0514, "financialCurrency": "USD", "symbol": "XERS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_105901792", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": 0.020999908, "fiftyDayAverageChangePercent": 0.004546419, "twoHundredDayAverageChange": 0.77884984, "twoHundredDayAverageChangePercent": 0.20171447, "priceToBook": -20.622223, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "longName": "Xeris Biopharma Holdings, Inc.", "regularMarketChangePercent": -0.64240277, "regularMarketPrice": 4.64, "marketState": "REGULAR", "shortName": "Xeris Biopharma Holdings, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "regularMarketChange": -0.03000021, "regularMarketDayRange": "4.54 - 4.705", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2395590, "fiftyTwoWeekLowChange": 2.61, "fiftyTwoWeekLowChangePercent": 1.2857143, "fiftyTwoWeekRange": "2.03 - 6.07", "fiftyTwoWeekHighChange": -1.4300003, "fiftyTwoWeekHighChangePercent": -0.23558488, "fiftyTwoWeekChangePercent": 126.69902, "earningsTimestamp": 1746702000, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754915400, "earningsCallTimestampStart": 1746707400, "earningsCallTimestampEnd": 1746707400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.29, "epsForward": -0.22, "epsCurrentYear": -0.09, "priceEpsCurrentYear": -51.555553, "corporateActions": [], "regularMarketTime": 1751396832, "displayName": "Xeris Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]